Opus Genetics (IRD) Interest Coverage Ratio Growth (1y) (2012 - 2021)
Opus Genetics (IRD) Interest Coverage Ratio Growth (1y) (2012 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 787.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -100.36% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 73.00% |
| 10 | Opus Genetics | 3.27 Mn | -56.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -150,042.80% |
| Dec 31, 2020 | -151.06% |
| Sep 30, 2020 | 16.52% |
| Jun 30, 2020 | 58.84% |
| Mar 31, 2020 | 31.96% |
| Dec 31, 2019 | 101.68% |
| Sep 30, 2019 | 54.99% |
| Jun 30, 2019 | 45.62% |
| Mar 31, 2019 | 40.51% |
| Dec 31, 2018 | -50.43% |
| Sep 30, 2018 | -34.67% |
| Jun 30, 2018 | -41.89% |
| Mar 31, 2018 | -80.75% |
| Dec 31, 2017 | 15.17% |
| Sep 30, 2017 | -2.01% |
| Jun 30, 2017 | 2.06% |
| Mar 31, 2017 | 26.91% |
| Dec 31, 2016 | 0.17% |
| Sep 30, 2016 | 29.98% |
| Jun 30, 2016 | 29.91% |